Four years after Spero Therapeutics received a complete response letter from the FDA, rejecting its oral treatment for ...

After disclosing a security breach last week concerning “a limited number of internal IT systems,” details on the cyber ...

TV spot for Exdensur, stepping up promotion of an asthma drug that th | GSK has launched the first direct-to-consumer TV spot ...

With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since ...

In February of 2024, shortly after Florida received sign-off on its Canadian import scheme from the FDA, Health Canada ...

Eighteen months after Novo Nordisk purchased a plant in the Czech Republic from Novavax, the Danish drugmaker said it is set to kick off the manufacturing of “supportive proteins” for next-generation ...

As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business.  | ...

DeepIntent has launched an agentic AI tool to help healthcare marketers more efficiently extract insights from databases ...

With the passage of another year in the biz, and another slate of company earnings stacked up against one another, Fierce is ...

Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) | ...

In patients with BTK-pretreated chronic lymphocytic leukemia (CLL), AbbVie and Roche’s Venclexta (venetoclax) is the drug to ...

Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the ...